GEA
BBP icon

Glen Eagle Advisors’s Virtus Biotech ETF BBP Stock Holding History

Glen Eagle Advisors’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.15K Hold
50
– – ﹤0.01% 776
2025
Q4 		$4K Hold
50
– – ﹤0.01% 803
2025
Q3 		$3.5K Hold
50
– – ﹤0.01% 832
2025
Q2 		$2.91K Hold
50
– – ﹤0.01% 802
2025
Q1 		$2.93K Hold
50
– – ﹤0.01% 798
2024
Q4 		$3K Hold
50
– – ﹤0.01% 823
2024
Q3 		$3.14K Hold
50
– – ﹤0.01% 844
2024
Q2 		$2.94K Hold
50
– – ﹤0.01% 844
2024
Q1 		$2.83K Hold
50
– – ﹤0.01% 861
2023
Q4 		$2.9K Hold
50
– – ﹤0.01% 816
2023
Q3 		$2.5K Hold
50
– – ﹤0.01% 825
2023
Q2 		$2.63K Buy
+50
New +$2.62K ﹤0.01% 835

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MSL
MILLINGTON SECURITIES, LLC Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return

Glen Eagle Advisors's BBP Position: Q1 2026 in Review

Glen Eagle Advisors held its Virtus Biotech ETF (BBP) position steady in Q1 2026 at 50 shares worth $4.15K. The position accounts for ﹤0.01% of the portfolio, ranked #776.

Glen Eagle Advisors first reported a position in BBP in Q2 2023 and has held it in 12 quarters since. 26 funds tracked by Wall St. Rank hold BBP as of Q1 2026.

  • Glen Eagle Advisors held 50 shares of Virtus Biotech ETF worth $4.15K as of Q1 2026.
  • Glen Eagle Advisors left its Virtus Biotech ETF share count unchanged in Q1 2026.
  • Virtus Biotech ETF made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q1 2026, its #776 holding.
  • Glen Eagle Advisors first reported a position in Virtus Biotech ETF in Q2 2023 and has held it in 12 quarters since.
  • 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2026.

Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.